PHARMA - Relationships

Word 1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 1 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT1 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	CAT2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Word 2 Count Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Co-occurrence Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Occurence-Centile Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Correlation Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	Overlap-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►	G-Metric Sort ascending Sort descending Add sort ascending Add sort descending Remove sorting ►
Headache		Disease	Drug	Amitiza (Lubiprostone)- FDA
CD4		Target	Target	Eotaxin-2/CCL24
Carcinoma		Disease	Target	Kallikrein-8
Infection		Disease	Target	Eotaxin-2/CCL24
Cancer		Disease	Target	464.1
744.1		Target	Target	464.1
CCL7		Target	Target	Eotaxin-2/CCL24
Brain Cancer		Disease	Target	Kallikrein-8
Cathepsin G		Target	Target	Kallikrein-8
Eotaxin		Target	Target	464.1
CD1A		Target	Target	AMAC-1
Acute Promyelocytic Leukemia		Disease	Target	464.1
Tissue-Type Plasminogen Activator		Target	Target	Kallikrein-8
CCL4		Target	Target	Eotaxin-2/CCL24
CD68		Target	Target	AMAC-1
CD68		Target	Target	Eotaxin-2/CCL24
Skin Disease		Disease	Target	Eotaxin-2/CCL24
Metastatic Breast Cancer		Disease	Drug	Aralen (Chloroquine)- FDA
Benign Prostatic Hyperplasia		Disease	Target	Kallikrein-8
Androgen Receptor		Target	Drug	Kaad-Cyclopamine
Graft Versus Host Disease		Disease	Target	AMAC-1
Chronic Pain		Disease	Target	Mu-Type Opioid Receptor
Dyspnea		Disease	Drug	Amitiza (Lubiprostone)- FDA
Non Small Cell Lung Cancer		Disease	Target	Kallikrein-8
Colon Cancer		Disease	Target	Complement Decay-Accelerating Factor
Osteoarthritis		Disease	Target	ALK Phos
Osteoarthritis		Disease	Target	Kallikrein-8
Poisoning		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	464.1
Prostate Cancer		Disease	Target	ALK Phos
Prostate Cancer		Disease	Target	Kallikrein-8
Renal Failure		Disease	Target	464.1
Renal Failure		Disease	Target	ALK Phos
Pneumonia		Disease	Target	ALK Phos
Anemia		Disease	Target	ALK Phos
Lung Cancer		Disease	Drug	Kaad-Cyclopamine
Lung Cancer		Disease	Target	Kallikrein-8
CD4		Target	Target	Complement Decay-Accelerating Factor
CD4		Target	Target	AMAC-1
Arthritis		Disease	Target	Eotaxin-2/CCL24
Arthritis		Disease	Target	Kallikrein-8
Shock		Disease	Target	Tegument Protein Vp16
Tuberculosis		Disease	Target	Eotaxin-2/CCL24
Depression		Disease	Target	Mu-Type Opioid Receptor
Diabetes		Disease	Drug	Kaad-Cyclopamine
Diabetes		Disease	Target	464.1
Diabetes		Disease	Target	ALK Phos
Carcinoma		Disease	Target	464.1
Cancer		Disease	Target	ALK Phos
Cancer		Disease	Drug	Amitiza (Lubiprostone)- FDA